The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
Omar Maoujoud,1,2 Samir Ahid,1 Yahia Cherrah1 1Research Team of Pharmacoepidemiology and Pharmacoeconomics, Medical and Pharmacy School, Mohammed V University, Rabat, 2Department of Nephrology and Dialysis, Military Hospital, Agadir, Morocco Objective: The purpose of this study was to determine the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-02-01
|
| Series: | International Journal of Nephrology and Renovascular Disease |
| Subjects: | |
| Online Access: | https://www.dovepress.com/the-cost-utility-of-treating-anemia-with-continuous-erythropoietin-rec-peer-reviewed-article-IJNRD |